In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's reply

L. Denneman, S. Cohen, M. H. Godfried, E. van Leeuwen, J. F. Nellen, T. W. Kuijpers, D. Pajkrt, A. van de Plas, C. Smit, A. M. Weijsenfeld, Henriette J. Scherpbier, Madeleine J. Bunders*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)596-598
Number of pages4
JournalAids
Volume31
Issue number4
DOIs
Publication statusPublished - 20 Feb 2017

Keywords

  • PREGNANCY
  • OUTCOMES
  • SAFETY

Cite this

Denneman, L., Cohen, S., Godfried, M. H., van Leeuwen, E., Nellen, J. F., Kuijpers, T. W., Pajkrt, D., van de Plas, A., Smit, C., Weijsenfeld, A. M., Scherpbier, H. J., & Bunders, M. J. (2017). In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's reply. Aids, 31(4), 596-598. https://doi.org/10.1097/QAD.0000000000001364